Label at a glance#

ProductKali bichromicum

Active ingredientPOTASSIUM DICHROMATE

Label structure8 sections

Indications and uses

To relieve the symptoms of sinuses.

Dosage and administration

Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

KALI BIC

USES

OTC - PURPOSE SECTION

To relieve the symptoms of sinuses.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of reach of children.

INDICATIONS

INDICATIONS & USAGE SECTION

Indications:

KALI BIC Sinuses

STOP USE AND ASK DOCTOR

WARNINGS SECTION

If symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adults: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides. Children: Dissolve 3 to 5 under the tongue three times a day or as directed by Lic. Practitioner. Take at greater intervals as condition subsides.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Sucrose/Lactose

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

The OTC potency range of KALI BIC is 3x–30x, 2c–30c, 200c, 1m, 10m, 50m, and CM.
KaliBic2023
Availability is subject to change.

All WHP single remedies are made to order; thus, the labels are printed on the same label stock as the orders are filled.

‘Bottle Size’ and ‘Potency’ vary on the label depending on customer choice.

Standard bottle sizes for pellet-form remedies are 2 dram, 4 dram, 1 ounce, 2 ounce, and 4 ounce.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68428-449-03	2025-01-30	C162847	48780-1	2cef2736-9c8e-d83d-e063-dadaa90ab31f	DRUG FACTS
68428-449-05	2025-01-30	C162847	48780-1	2cef2736-9c8e-d83d-e063-dadaa90ab31f	DRUG FACTS
68428-449-06	2025-01-30	C162847	48780-1	2cef2736-9c8e-d83d-e063-dadaa90ab31f	DRUG FACTS
68428-449-11	2025-01-30	C162847	48780-1	2cef2736-9c8e-d83d-e063-dadaa90ab31f	DRUG FACTS
68428-449-12	2025-01-30	C162847	48780-1	2cef2736-9c8e-d83d-e063-dadaa90ab31f	DRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
68428-449-03	Kali bichromicum	75 in 1 VIAL, GLASS	PELLET	75	3
68428-449-05	Kali bichromicum	150 in 1 VIAL, GLASS	PELLET	150	3
68428-449-06	Kali bichromicum	1200 in 1 BOTTLE, GLASS	PELLET	1200	3
68428-449-11	Kali bichromicum	300 in 1 BOTTLE, GLASS	PELLET	300	3
68428-449-12	Kali bichromicum	600 in 1 BOTTLE, GLASS	PELLET	600	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68428-449	KALI BICHROMICUM (POTASSIUM DICHROMATE) PELLET [WASHINGTON HOMEOPATHIC PRODUCTS]	3	Legacy NDC, 5 package rows	20231020_2d3d78e6-dc3b-44b8-be84-0f1cfd1be003.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

Kali bichromicum
POTASSIUM DICHROMATE
LACTOSE
DICHROMATE ION
SUCROSE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68428-449	68428-449-03, 68428-449-05, 68428-449-11, 68428-449-12, 68428-449-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
LACTOSE	J2B2A4N98G	IACT
POTASSIUM DICHROMATE	T4423S18FM	ACTIB
SUCROSE	C151H8M554	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
0812aed3-1d00-751d-e063-6294a90acf78			2d3d78e6-dc3b-44b8-be84-0f1cfd1be003	2023-10-19	Warnings	Exact identifier spl id: 0812aed3-1d00-751d-e063-6294a90acf78 spl set id: 2d3d78e6-dc3b-44b8-be84-0f1cfd1be003

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.